Global Central Vascular Access Device

Central Vascular Access Device Comprehensive Study by Type (Peripherally inserted central catheters (PICC), Temporary (Tunneled catheters), Permanent (Non tunneled catheters), Implanted ports), Application (Drug administration, Fluid and nutrition administration, Blood transfusion, Diagnostics & testing), End User (Hospitals, Clinics and ambulatory care centers, Others) Players and Region - Global Market Outlook to 2026

Central Vascular Access Device Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Central Vascular Access Device Market?

Central venous access devices (CVADs) are devices that are inserted into the body through a vein to enable the administration of fluids, blood products, medication and other therapies to the bloodstream. Secure and dependable venous access is a foundation being taken care of by hospitalized grown-up patients, just as for an assortment of outpatient circumstances. Focal venous access (ie, the inclusion of a vascular catheter with the end goal that the tip ends in a profound vein of the neck, chest, or mid-region) is a critical segment of this training. Patients regularly need focal venous access for signs including progressing hemodynamic observing, troublesome venous access, or long haul intravenous treatment (eg, antimicrobial treatment, liquid treatment, chemotherapy). An assortment of focal venous catheters and gadgets are accessible to accomplish such access, each with its own dangers and advantages. Explicit clinical circumstances that may show the requirement for focal venous access are checked on independently

The market study is being classified by Type (Peripherally inserted central catheters (PICC), Temporary (Tunneled catheters), Permanent (Non tunneled catheters) and Implanted ports), by Application (Drug administration, Fluid and nutrition administration, Blood transfusion and Diagnostics & testing) and major geographies with country level break-up.

Vygon Ltd. (United Kingdom), Ameco Medical (Egypt), AngioDynamics (United States), Romsons Scientific & Surgical Pvt. Ltd. (India), PRODIMED (France), Becton, Dickinson, and Company (United States), C. R. Bard, Inc. (United States), Smiths Medical, Inc. (United Kingdom), Teleflex Incorporated (United States) and B.Braun Melsungen AG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Edwards Lifesciences Corporation (United States) and Terumo Corporation (Japan).

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Central Vascular Access Device market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Central Vascular Access Device market by Type, Application and Region.

On the basis of geography, the market of Central Vascular Access Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The rise in the Number of Chemotherapy Procedures
  • Increasing Use of Vascular Access Devices in Pediatric Patients

Market Trend
  • With growing patient involvement in the decisions affecting their care, there is little evidence to suggest the user involvement in the selection of vascular access devices.

Restraints
  • Risk of catheter-related bloodstream infection

Opportunities
  • Technological Advancements and Growing Prevalence of Lifestyle Disease

Challenges
  • Risks Associated With Vascular Access Device





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Central Vascular Access Device Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Peripherally inserted central catheters (PICC)
  • Temporary (Tunneled catheters)
  • Permanent (Non tunneled catheters)
  • Implanted ports
By Application
  • Drug administration
  • Fluid and nutrition administration
  • Blood transfusion
  • Diagnostics & testing
By End User
  • Hospitals
  • Clinics and ambulatory care centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rise in the Number of Chemotherapy Procedures
      • 3.2.2. Increasing Use of Vascular Access Devices in Pediatric Patients
    • 3.3. Market Challenges
      • 3.3.1. Risks Associated With Vascular Access Device
    • 3.4. Market Trends
      • 3.4.1. With growing patient involvement in the decisions affecting their care, there is little evidence to suggest the user involvement in the selection of vascular access devices.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Central Vascular Access Device, by Type, Application, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Central Vascular Access Device (Value)
      • 5.2.1. Global Central Vascular Access Device by: Type (Value)
        • 5.2.1.1. Peripherally inserted central catheters (PICC)
        • 5.2.1.2. Temporary (Tunneled catheters)
        • 5.2.1.3. Permanent (Non tunneled catheters)
        • 5.2.1.4. Implanted ports
      • 5.2.2. Global Central Vascular Access Device by: Application (Value)
        • 5.2.2.1. Drug administration
        • 5.2.2.2. Fluid and nutrition administration
        • 5.2.2.3. Blood transfusion
        • 5.2.2.4. Diagnostics & testing
      • 5.2.3. Global Central Vascular Access Device by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics and ambulatory care centers
        • 5.2.3.3. Others
      • 5.2.4. Global Central Vascular Access Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Central Vascular Access Device (Volume)
      • 5.3.1. Global Central Vascular Access Device by: Type (Volume)
        • 5.3.1.1. Peripherally inserted central catheters (PICC)
        • 5.3.1.2. Temporary (Tunneled catheters)
        • 5.3.1.3. Permanent (Non tunneled catheters)
        • 5.3.1.4. Implanted ports
      • 5.3.2. Global Central Vascular Access Device by: Application (Volume)
        • 5.3.2.1. Drug administration
        • 5.3.2.2. Fluid and nutrition administration
        • 5.3.2.3. Blood transfusion
        • 5.3.2.4. Diagnostics & testing
      • 5.3.3. Global Central Vascular Access Device by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics and ambulatory care centers
        • 5.3.3.3. Others
      • 5.3.4. Global Central Vascular Access Device Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Central Vascular Access Device (Price)
      • 5.4.1. Global Central Vascular Access Device by: Type (Price)
  • 6. Central Vascular Access Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Vygon Ltd. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ameco Medical (Egypt)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AngioDynamics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Romsons Scientific & Surgical Pvt. Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PRODIMED (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton, Dickinson, and Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. C. R. Bard, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smiths Medical, Inc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Teleflex Incorporated (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. B.Braun Melsungen AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Central Vascular Access Device Sale, by Type, Application, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Central Vascular Access Device (Value)
      • 7.2.1. Global Central Vascular Access Device by: Type (Value)
        • 7.2.1.1. Peripherally inserted central catheters (PICC)
        • 7.2.1.2. Temporary (Tunneled catheters)
        • 7.2.1.3. Permanent (Non tunneled catheters)
        • 7.2.1.4. Implanted ports
      • 7.2.2. Global Central Vascular Access Device by: Application (Value)
        • 7.2.2.1. Drug administration
        • 7.2.2.2. Fluid and nutrition administration
        • 7.2.2.3. Blood transfusion
        • 7.2.2.4. Diagnostics & testing
      • 7.2.3. Global Central Vascular Access Device by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics and ambulatory care centers
        • 7.2.3.3. Others
      • 7.2.4. Global Central Vascular Access Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Central Vascular Access Device (Volume)
      • 7.3.1. Global Central Vascular Access Device by: Type (Volume)
        • 7.3.1.1. Peripherally inserted central catheters (PICC)
        • 7.3.1.2. Temporary (Tunneled catheters)
        • 7.3.1.3. Permanent (Non tunneled catheters)
        • 7.3.1.4. Implanted ports
      • 7.3.2. Global Central Vascular Access Device by: Application (Volume)
        • 7.3.2.1. Drug administration
        • 7.3.2.2. Fluid and nutrition administration
        • 7.3.2.3. Blood transfusion
        • 7.3.2.4. Diagnostics & testing
      • 7.3.3. Global Central Vascular Access Device by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics and ambulatory care centers
        • 7.3.3.3. Others
      • 7.3.4. Global Central Vascular Access Device Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Central Vascular Access Device (Price)
      • 7.4.1. Global Central Vascular Access Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Central Vascular Access Device: by Type(USD Million)
  • Table 2. Central Vascular Access Device Peripherally inserted central catheters (PICC) , by Region USD Million (2015-2020)
  • Table 3. Central Vascular Access Device Temporary (Tunneled catheters) , by Region USD Million (2015-2020)
  • Table 4. Central Vascular Access Device Permanent (Non tunneled catheters) , by Region USD Million (2015-2020)
  • Table 5. Central Vascular Access Device Implanted ports , by Region USD Million (2015-2020)
  • Table 6. Central Vascular Access Device: by Application(USD Million)
  • Table 7. Central Vascular Access Device Drug administration , by Region USD Million (2015-2020)
  • Table 8. Central Vascular Access Device Fluid and nutrition administration , by Region USD Million (2015-2020)
  • Table 9. Central Vascular Access Device Blood transfusion , by Region USD Million (2015-2020)
  • Table 10. Central Vascular Access Device Diagnostics & testing , by Region USD Million (2015-2020)
  • Table 11. Central Vascular Access Device: by End User(USD Million)
  • Table 12. Central Vascular Access Device Hospitals , by Region USD Million (2015-2020)
  • Table 13. Central Vascular Access Device Clinics and ambulatory care centers , by Region USD Million (2015-2020)
  • Table 14. Central Vascular Access Device Others , by Region USD Million (2015-2020)
  • Table 15. South America Central Vascular Access Device, by Country USD Million (2015-2020)
  • Table 16. South America Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 17. South America Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 18. South America Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 19. Brazil Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 20. Brazil Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 21. Brazil Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 22. Argentina Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 23. Argentina Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 24. Argentina Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 25. Rest of South America Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 26. Rest of South America Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 27. Rest of South America Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 28. Asia Pacific Central Vascular Access Device, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 31. Asia Pacific Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 32. China Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 33. China Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 34. China Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 35. Japan Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 36. Japan Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 37. Japan Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 38. India Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 39. India Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 40. India Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 41. South Korea Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 42. South Korea Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 43. South Korea Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 44. Taiwan Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 45. Taiwan Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 46. Taiwan Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 47. Australia Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 48. Australia Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 49. Australia Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 53. Europe Central Vascular Access Device, by Country USD Million (2015-2020)
  • Table 54. Europe Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 55. Europe Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 56. Europe Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 57. Germany Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 58. Germany Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 59. Germany Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 60. France Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 61. France Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 62. France Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 63. Italy Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 64. Italy Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 65. Italy Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 66. United Kingdom Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 67. United Kingdom Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 68. United Kingdom Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 69. Netherlands Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 70. Netherlands Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 71. Netherlands Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 72. Rest of Europe Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 74. Rest of Europe Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 75. MEA Central Vascular Access Device, by Country USD Million (2015-2020)
  • Table 76. MEA Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 77. MEA Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 78. MEA Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 79. Middle East Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 80. Middle East Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 81. Middle East Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 82. Africa Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 83. Africa Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 84. Africa Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 85. North America Central Vascular Access Device, by Country USD Million (2015-2020)
  • Table 86. North America Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 87. North America Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 88. North America Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 89. United States Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 90. United States Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 91. United States Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 92. Canada Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 93. Canada Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 94. Canada Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 95. Mexico Central Vascular Access Device, by Type USD Million (2015-2020)
  • Table 96. Mexico Central Vascular Access Device, by Application USD Million (2015-2020)
  • Table 97. Mexico Central Vascular Access Device, by End User USD Million (2015-2020)
  • Table 98. Central Vascular Access Device Sales: by Type(K Units)
  • Table 99. Central Vascular Access Device Sales Peripherally inserted central catheters (PICC) , by Region K Units (2015-2020)
  • Table 100. Central Vascular Access Device Sales Temporary (Tunneled catheters) , by Region K Units (2015-2020)
  • Table 101. Central Vascular Access Device Sales Permanent (Non tunneled catheters) , by Region K Units (2015-2020)
  • Table 102. Central Vascular Access Device Sales Implanted ports , by Region K Units (2015-2020)
  • Table 103. Central Vascular Access Device Sales: by Application(K Units)
  • Table 104. Central Vascular Access Device Sales Drug administration , by Region K Units (2015-2020)
  • Table 105. Central Vascular Access Device Sales Fluid and nutrition administration , by Region K Units (2015-2020)
  • Table 106. Central Vascular Access Device Sales Blood transfusion , by Region K Units (2015-2020)
  • Table 107. Central Vascular Access Device Sales Diagnostics & testing , by Region K Units (2015-2020)
  • Table 108. Central Vascular Access Device Sales: by End User(K Units)
  • Table 109. Central Vascular Access Device Sales Hospitals , by Region K Units (2015-2020)
  • Table 110. Central Vascular Access Device Sales Clinics and ambulatory care centers , by Region K Units (2015-2020)
  • Table 111. Central Vascular Access Device Sales Others , by Region K Units (2015-2020)
  • Table 112. South America Central Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 113. South America Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 114. South America Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 115. South America Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 116. Brazil Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 117. Brazil Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 118. Brazil Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 119. Argentina Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 120. Argentina Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 121. Argentina Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 122. Rest of South America Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 123. Rest of South America Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 124. Rest of South America Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 125. Asia Pacific Central Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 126. Asia Pacific Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 127. Asia Pacific Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 128. Asia Pacific Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 129. China Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 130. China Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 131. China Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 132. Japan Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 133. Japan Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 134. Japan Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 135. India Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 136. India Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 137. India Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 138. South Korea Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 139. South Korea Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 140. South Korea Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 141. Taiwan Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 142. Taiwan Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 143. Taiwan Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 144. Australia Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 145. Australia Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 146. Australia Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 148. Rest of Asia-Pacific Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 149. Rest of Asia-Pacific Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 150. Europe Central Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 151. Europe Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 152. Europe Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 153. Europe Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 154. Germany Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 155. Germany Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 156. Germany Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 157. France Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 158. France Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 159. France Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 160. Italy Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 161. Italy Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 162. Italy Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 163. United Kingdom Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 164. United Kingdom Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 165. United Kingdom Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 166. Netherlands Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 167. Netherlands Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 168. Netherlands Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 169. Rest of Europe Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 170. Rest of Europe Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 171. Rest of Europe Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 172. MEA Central Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 173. MEA Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 174. MEA Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 175. MEA Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 176. Middle East Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 177. Middle East Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 178. Middle East Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 179. Africa Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 180. Africa Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 181. Africa Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 182. North America Central Vascular Access Device Sales, by Country K Units (2015-2020)
  • Table 183. North America Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 184. North America Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 185. North America Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 186. United States Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 187. United States Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 188. United States Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 189. Canada Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 190. Canada Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 191. Canada Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 192. Mexico Central Vascular Access Device Sales, by Type K Units (2015-2020)
  • Table 193. Mexico Central Vascular Access Device Sales, by Application K Units (2015-2020)
  • Table 194. Mexico Central Vascular Access Device Sales, by End User K Units (2015-2020)
  • Table 195. Central Vascular Access Device: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Central Vascular Access Device: by Type(USD Million)
  • Table 207. Central Vascular Access Device Peripherally inserted central catheters (PICC) , by Region USD Million (2021-2026)
  • Table 208. Central Vascular Access Device Temporary (Tunneled catheters) , by Region USD Million (2021-2026)
  • Table 209. Central Vascular Access Device Permanent (Non tunneled catheters) , by Region USD Million (2021-2026)
  • Table 210. Central Vascular Access Device Implanted ports , by Region USD Million (2021-2026)
  • Table 211. Central Vascular Access Device: by Application(USD Million)
  • Table 212. Central Vascular Access Device Drug administration , by Region USD Million (2021-2026)
  • Table 213. Central Vascular Access Device Fluid and nutrition administration , by Region USD Million (2021-2026)
  • Table 214. Central Vascular Access Device Blood transfusion , by Region USD Million (2021-2026)
  • Table 215. Central Vascular Access Device Diagnostics & testing , by Region USD Million (2021-2026)
  • Table 216. Central Vascular Access Device: by End User(USD Million)
  • Table 217. Central Vascular Access Device Hospitals , by Region USD Million (2021-2026)
  • Table 218. Central Vascular Access Device Clinics and ambulatory care centers , by Region USD Million (2021-2026)
  • Table 219. Central Vascular Access Device Others , by Region USD Million (2021-2026)
  • Table 220. South America Central Vascular Access Device, by Country USD Million (2021-2026)
  • Table 221. South America Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 222. South America Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 223. South America Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 224. Brazil Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 225. Brazil Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 226. Brazil Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 227. Argentina Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 228. Argentina Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 229. Argentina Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 230. Rest of South America Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 231. Rest of South America Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 232. Rest of South America Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 233. Asia Pacific Central Vascular Access Device, by Country USD Million (2021-2026)
  • Table 234. Asia Pacific Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 235. Asia Pacific Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 236. Asia Pacific Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 237. China Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 238. China Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 239. China Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 240. Japan Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 241. Japan Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 242. Japan Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 243. India Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 244. India Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 245. India Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 246. South Korea Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 247. South Korea Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 248. South Korea Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 249. Taiwan Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 250. Taiwan Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 251. Taiwan Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 252. Australia Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 253. Australia Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 254. Australia Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 255. Rest of Asia-Pacific Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 256. Rest of Asia-Pacific Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 257. Rest of Asia-Pacific Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 258. Europe Central Vascular Access Device, by Country USD Million (2021-2026)
  • Table 259. Europe Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 260. Europe Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 261. Europe Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 262. Germany Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 263. Germany Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 264. Germany Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 265. France Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 266. France Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 267. France Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 268. Italy Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 269. Italy Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 270. Italy Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 271. United Kingdom Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 272. United Kingdom Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 273. United Kingdom Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 274. Netherlands Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 275. Netherlands Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 276. Netherlands Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 277. Rest of Europe Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 278. Rest of Europe Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 279. Rest of Europe Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 280. MEA Central Vascular Access Device, by Country USD Million (2021-2026)
  • Table 281. MEA Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 282. MEA Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 283. MEA Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 284. Middle East Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 285. Middle East Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 286. Middle East Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 287. Africa Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 288. Africa Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 289. Africa Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 290. North America Central Vascular Access Device, by Country USD Million (2021-2026)
  • Table 291. North America Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 292. North America Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 293. North America Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 294. United States Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 295. United States Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 296. United States Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 297. Canada Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 298. Canada Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 299. Canada Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 300. Mexico Central Vascular Access Device, by Type USD Million (2021-2026)
  • Table 301. Mexico Central Vascular Access Device, by Application USD Million (2021-2026)
  • Table 302. Mexico Central Vascular Access Device, by End User USD Million (2021-2026)
  • Table 303. Central Vascular Access Device Sales: by Type(K Units)
  • Table 304. Central Vascular Access Device Sales Peripherally inserted central catheters (PICC) , by Region K Units (2021-2026)
  • Table 305. Central Vascular Access Device Sales Temporary (Tunneled catheters) , by Region K Units (2021-2026)
  • Table 306. Central Vascular Access Device Sales Permanent (Non tunneled catheters) , by Region K Units (2021-2026)
  • Table 307. Central Vascular Access Device Sales Implanted ports , by Region K Units (2021-2026)
  • Table 308. Central Vascular Access Device Sales: by Application(K Units)
  • Table 309. Central Vascular Access Device Sales Drug administration , by Region K Units (2021-2026)
  • Table 310. Central Vascular Access Device Sales Fluid and nutrition administration , by Region K Units (2021-2026)
  • Table 311. Central Vascular Access Device Sales Blood transfusion , by Region K Units (2021-2026)
  • Table 312. Central Vascular Access Device Sales Diagnostics & testing , by Region K Units (2021-2026)
  • Table 313. Central Vascular Access Device Sales: by End User(K Units)
  • Table 314. Central Vascular Access Device Sales Hospitals , by Region K Units (2021-2026)
  • Table 315. Central Vascular Access Device Sales Clinics and ambulatory care centers , by Region K Units (2021-2026)
  • Table 316. Central Vascular Access Device Sales Others , by Region K Units (2021-2026)
  • Table 317. South America Central Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 318. South America Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 319. South America Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 320. South America Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 321. Brazil Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 322. Brazil Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 323. Brazil Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 324. Argentina Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 325. Argentina Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 326. Argentina Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 327. Rest of South America Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 328. Rest of South America Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 329. Rest of South America Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 330. Asia Pacific Central Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 331. Asia Pacific Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 332. Asia Pacific Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 333. Asia Pacific Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 334. China Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 335. China Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 336. China Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 337. Japan Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 338. Japan Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 339. Japan Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 340. India Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 341. India Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 342. India Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 343. South Korea Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 344. South Korea Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 345. South Korea Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 346. Taiwan Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 347. Taiwan Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 348. Taiwan Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 349. Australia Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 350. Australia Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 351. Australia Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 352. Rest of Asia-Pacific Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 353. Rest of Asia-Pacific Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 354. Rest of Asia-Pacific Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 355. Europe Central Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 356. Europe Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 357. Europe Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 358. Europe Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 359. Germany Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 360. Germany Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 361. Germany Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 362. France Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 363. France Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 364. France Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 365. Italy Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 366. Italy Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 367. Italy Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 368. United Kingdom Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 369. United Kingdom Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 370. United Kingdom Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 371. Netherlands Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 372. Netherlands Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 373. Netherlands Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 374. Rest of Europe Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 375. Rest of Europe Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 376. Rest of Europe Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 377. MEA Central Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 378. MEA Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 379. MEA Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 380. MEA Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 381. Middle East Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 382. Middle East Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 383. Middle East Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 384. Africa Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 385. Africa Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 386. Africa Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 387. North America Central Vascular Access Device Sales, by Country K Units (2021-2026)
  • Table 388. North America Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 389. North America Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 390. North America Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 391. United States Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 392. United States Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 393. United States Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 394. Canada Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 395. Canada Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 396. Canada Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 397. Mexico Central Vascular Access Device Sales, by Type K Units (2021-2026)
  • Table 398. Mexico Central Vascular Access Device Sales, by Application K Units (2021-2026)
  • Table 399. Mexico Central Vascular Access Device Sales, by End User K Units (2021-2026)
  • Table 400. Central Vascular Access Device: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Central Vascular Access Device: by Type USD Million (2015-2020)
  • Figure 5. Global Central Vascular Access Device: by Application USD Million (2015-2020)
  • Figure 6. Global Central Vascular Access Device: by End User USD Million (2015-2020)
  • Figure 7. South America Central Vascular Access Device Share (%), by Country
  • Figure 8. Asia Pacific Central Vascular Access Device Share (%), by Country
  • Figure 9. Europe Central Vascular Access Device Share (%), by Country
  • Figure 10. MEA Central Vascular Access Device Share (%), by Country
  • Figure 11. North America Central Vascular Access Device Share (%), by Country
  • Figure 12. Global Central Vascular Access Device: by Type K Units (2015-2020)
  • Figure 13. Global Central Vascular Access Device: by Application K Units (2015-2020)
  • Figure 14. Global Central Vascular Access Device: by End User K Units (2015-2020)
  • Figure 15. South America Central Vascular Access Device Share (%), by Country
  • Figure 16. Asia Pacific Central Vascular Access Device Share (%), by Country
  • Figure 17. Europe Central Vascular Access Device Share (%), by Country
  • Figure 18. MEA Central Vascular Access Device Share (%), by Country
  • Figure 19. North America Central Vascular Access Device Share (%), by Country
  • Figure 20. Global Central Vascular Access Device: by Type USD/Units (2015-2020)
  • Figure 21. Global Central Vascular Access Device share by Players 2020 (%)
  • Figure 22. Global Central Vascular Access Device share by Players (Top 3) 2020(%)
  • Figure 23. Global Central Vascular Access Device share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Vygon Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Vygon Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Ameco Medical (Egypt) Revenue, Net Income and Gross profit
  • Figure 28. Ameco Medical (Egypt) Revenue: by Geography 2020
  • Figure 29. AngioDynamics (United States) Revenue, Net Income and Gross profit
  • Figure 30. AngioDynamics (United States) Revenue: by Geography 2020
  • Figure 31. Romsons Scientific & Surgical Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 32. Romsons Scientific & Surgical Pvt. Ltd. (India) Revenue: by Geography 2020
  • Figure 33. PRODIMED (France) Revenue, Net Income and Gross profit
  • Figure 34. PRODIMED (France) Revenue: by Geography 2020
  • Figure 35. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 37. C. R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. C. R. Bard, Inc. (United States) Revenue: by Geography 2020
  • Figure 39. Smiths Medical, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. Smiths Medical, Inc. (United Kingdom) Revenue: by Geography 2020
  • Figure 41. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 42. Teleflex Incorporated (United States) Revenue: by Geography 2020
  • Figure 43. B.Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 44. B.Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 45. Global Central Vascular Access Device: by Type USD Million (2021-2026)
  • Figure 46. Global Central Vascular Access Device: by Application USD Million (2021-2026)
  • Figure 47. Global Central Vascular Access Device: by End User USD Million (2021-2026)
  • Figure 48. South America Central Vascular Access Device Share (%), by Country
  • Figure 49. Asia Pacific Central Vascular Access Device Share (%), by Country
  • Figure 50. Europe Central Vascular Access Device Share (%), by Country
  • Figure 51. MEA Central Vascular Access Device Share (%), by Country
  • Figure 52. North America Central Vascular Access Device Share (%), by Country
  • Figure 53. Global Central Vascular Access Device: by Type K Units (2021-2026)
  • Figure 54. Global Central Vascular Access Device: by Application K Units (2021-2026)
  • Figure 55. Global Central Vascular Access Device: by End User K Units (2021-2026)
  • Figure 56. South America Central Vascular Access Device Share (%), by Country
  • Figure 57. Asia Pacific Central Vascular Access Device Share (%), by Country
  • Figure 58. Europe Central Vascular Access Device Share (%), by Country
  • Figure 59. MEA Central Vascular Access Device Share (%), by Country
  • Figure 60. North America Central Vascular Access Device Share (%), by Country
  • Figure 61. Global Central Vascular Access Device: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Vygon Ltd. (United Kingdom)
  • Ameco Medical (Egypt)
  • AngioDynamics (United States)
  • Romsons Scientific & Surgical Pvt. Ltd. (India)
  • PRODIMED (France)
  • Becton, Dickinson, and Company (United States)
  • C. R. Bard, Inc. (United States)
  • Smiths Medical, Inc. (United Kingdom)
  • Teleflex Incorporated (United States)
  • B.Braun Melsungen AG (Germany)
Additional players considered in the study are as follows:
Edwards Lifesciences Corporation (United States) , Terumo Corporation (Japan)
Select User Access Type

Key Highlights of Report


Mar 2022 221 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Central Vascular Access Device Quantitative research analysis
Global Central Vascular Access Device Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"The rise in the Number of Chemotherapy Procedures " is seen as one of major growth factors of Central Vascular Access Device Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Central Vascular Access Device Market in coming years.

Know More About Global Central Vascular Access Device Report?

Have a Query? Click Here

Other Related Reports

Holmium Laser Lithotripsy Devices Comprehensive Study by Type (20W, 30W, 40W, Others), Application (Hospitals, Clinics, Others), Portability (Fixed, Mobile) Players and Region - Global Market Outlook...
$ 3500
Nasoenteric Feeding Tube Comprehensive Study by Type (Nasogastric Feeding Tubes, Nasojejunal Feeding Tubes, Nasoduodenal Feeding Tubes), Application (Oncology, Gastroenterology, Neurology, Diabetes, ...
$ 3650
Cranio Maxillofacial Implants Comprehensive Study by Type (Mid Face Implants, Mandibular Orthognathic Implants, Cranial or Neuro Implants, Contourable Mesh, Bone Graft Substitutes, Distraction System...
$ 3800
DNA Library Preparation Kits Comprehensive Study by Application (Basic Research, Drug Discovery, Forensic Testing, Biopharmaceutical Production, Other), Technique (Single-molecule real-time method, I...
$ 3750
Cone Beam Imaging Comprehensive Study by Type (Standing, Seated, Supine), Application (Dentistry Surgery, Maxillofacial Surgery), End User (Hospitals, Private Practices, Academic & Research Institute...
$ 3500
Anesthesia Gas Blender Comprehensive Study by Type (Pipeline Blending , Vortex Blending , Static Blending), Application (Operating Room , Intensive Care Unit , Others), Flow Meter (Dual Flow Meter, T...
$ 3450